[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"meniscus-tears\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:meniscus-tears":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100634400","evaluation-of-the-performance-and-safety-of-a-single-dose-hyaluronic-acid-promovia-hydro-balance-in-the-treatment-of-non-traumatic-degenerative-meniscus-tears-100634400",false,"NCT07539194","Evaluation of the Performance and Safety of a Single-dose Hyaluronic Acid (Promovia Hydro Balance) in the Treatment of Non-traumatic Degenerative Meniscus Tears","Inclusion Criteria:\n\n* \\- Age between 35 and 75 years at the time of administration.\n* Presence of a symptomatic degenerative meniscus tear, not related to acute trauma, documented by MRI.\n* Positive meniscal tests.\n* Pain intensity NRS ≥ 4.\n* Willingness to participate in physical therapy or light exercise.\n* Informed consent received, understood, and signed by the patient for active participation in the study and for the processing of personal data.\n* Ability of the patient to understand the study conditions and to participate for the entire duration of the study.\n\nExclusion Criteria:\n\n* \\- Patients with traumatic meniscus tears.\n* Patients with a meniscal tear requiring surgical treatment (FLAP tear, radial tear, RAMP tear).\n* Patients with severe knee osteoarthritis.\n* Patients with axial deviation greater than 10°.\n* Patients who have undergone meniscal or ligament surgery in the previous 12 months.\n* Patients with rheumatic diseases or chondrocalcinosis.\n* Patients with signs of possible infection in the affected joint or a skin disease involving the knee (e.g., dermatitis, psoriasis).\n* Patients with diabetes.\n* Patients with coagulopathies, platelet aggregation disorders, or those receiving oral anticoagulants or antiplatelet drugs.\n* Patients receiving intra-articular corticosteroids or hyaluronic acid in the previous 12 months.\n* Pregnant or breastfeeding patients.","ALL","35 Years","75 Years",{"count":19,"type":20},25,"ESTIMATED","INTERVENTIONAL",[23],"NA","Evaluation of the performance and safety of a single-dose hyaluronic acid (Promovia hydro balance) in the treatment of non-traumatic degenerative meniscus tears",[26],"Meniscus Tears",[28,29,30,31],"meniscus tears","promovia hydro balance","hyaluronic acid","viscosupplementation","RECRUITING","2026-04-13",{"date":35,"type":36},"2026-04-20","ACTUAL",{"date":38,"type":20},"2026-04-30",{"date":40,"type":20},"2027-01-30",{"name":42,"class":43},"Innate srl","INDUSTRY",1,{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":4,"eligibilityCriteria":51,"healthyVolunteers":11,"sex":15,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":21,"phases":56,"briefSummary":57,"conditions":58,"keywords":61,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":44},"100591390","a-comparison-of-outcomes-after-anterior-cruciate-ligament-acl-or-anterior-cruciate-ligament-and-meniscus-aclmeniscus-surgery-using-semiconductor-fabric-products-100591390","NCT06979804","A Comparison of Outcomes After Anterior Cruciate Ligament (ACL) or Anterior Cruciate Ligament and Meniscus (ACL+Meniscus) Surgery Using Semiconductor Fabric Products","A Comparison of Outcomes After Anterior Cruciate Ligament (ACL) or Anterior Cruciate Ligament and Meniscus (ACL+Meniscus) Surgery Using Semiconductor Fabric Products: A Randomized, Double-Blinded, Placebo-Controlled Prospective Clinical Study","Inclusion Criteria:\n\n* Patients undergoing ACL or ACL+Meniscus surgery\n* Age 16 - 65\n* Patients with Body Mass Index (BMI) \\\u003C40\n* Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.\n* Patients who are willing and able to sign corresponding research subject consent\u002Fassent form.\n\nExclusion Criteria:\n\n* Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease\n* Patient has severe medical condition, including recent myocardial infarction, unstable angina, heart failure, severe anemia\n* Patient has had prior surgical treatment of the knee in the last 5 years or injection treatment(s) in the last 6 months\n* Patient has chronic pain conditions unrelated to knee condition\n* Patient has auto-immune or auto-inflammatory diseases\n* Patient has poorly controlled diabetes (HgA1c \\> 7.5)\n* Patient has BMI \\> 39.9\n* Patient has varicosities on the operative leg\n* Patient has severe peripheral artery disease (ABI \\\u003C 0.6)\n* Patient is considered a pain management patient\n* Patient has had previous blood clots or stroke\n* Patient has used tobacco within the last 90 days\n* Patient is not within the ages of 16-65\n* Patient has an active infection (local or systemic), or an open (non-surgical) wound in the areas of product application\n* Patient is unwilling or unable to sign the corresponding research subject consent\u002Fassent form\n* Patient meets any other criteria or has any other condition that, in the opinion of the investigator, would prevent them from completing the study or that, in the opinion of the investigator, would confound study results.","16 Years","65 Years",{"count":55,"type":20},135,[23],"The goal of this clinical trial is to determine the effect of semiconductor sleeves on the treatment of Anterior Cruciate Ligament (ACL) or Anterior Cruciate Ligament and Meniscus (ACL+Meniscus) arthroscopic surgery. The effect of the sleeves will be analyzed through patient reported and clinically measured outcomes. The main questions it aims to answer are:\n\n* Do the semiconductor sleeves improve the functional outcomes compared to the placebo?\n* Will patients experience improved functional outcomes in a shorter period of time compared to the placebo?\n\nResearchers will compare semiconductor fabric sleeves to a placebo (a look-alike sleeve that contains no semiconductor material) to see if the semiconductor fabric better treats ACL and ACL+meniscus surgical patients.\n\nParticipants will:\n\n* Wear semiconductor or placebo leg sleeve for 4 weeks and knee sleeve for the following 12 weeks\n* Complete patient reported outcome surveys",[59,26,60],"ACL Reconstruction","Anterior Cruciate Ligament Rupture",[62,63,64,65,66,67],"ACL","Meniscus tear","ACL tear","Compression sleeve","Semiconductor fabric","ACL reconstruction","2025-05-19",{"date":70,"type":36},"2025-05-22",{"date":72,"type":36},"2024-09-11",{"date":74,"type":20},"2026-10-01",{"name":76,"class":77},"Illinois Center for Orthopaedic Research and Education","OTHER"]